We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNST icon
11201
CALL
The Honest Company
HNST
$608M
$120K ﹤0.01%
41,000
-29,300
-42% -$106K
NIM icon
11202
Nuveen Select Maturities Municipal Fund
NIM
$116M
$120K ﹤0.01%
13,029
-47,937
-79% -$446K
PILL icon
11203
Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
$23M
$120K ﹤0.01%
11,132
-4,252
-28% -$47.6K
SDEM icon
11204
Global X MSCI SuperDividend Emerging Markets ETF
SDEM
$45.1M
$120K ﹤0.01%
4,688
-12,223
-72% -$344K
ALPN
11205
DELISTED
Alpine Immune Sciences Inc
ALPN
$120K ﹤0.01%
14,121
+1,700
+14% +$14.7K
MDVL
11206
PUT
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$120K ﹤0.01%
+1,574
New +$138K
RCACU
11207
DELISTED
Revelstone Capital Acquisition Corp. Unit
RCACU
$120K ﹤0.01%
+12,199
New +$121K
ALLO icon
11208
PUT
Allogene Therapeutics
ALLO
$698M
$119K ﹤0.01%
10,400
-28,300
-73% -$251K
DMAC icon
11209
CALL
DiaMedica Therapeutics
DMAC
$345M
$119K ﹤0.01%
59,000
+12,500
+27% +$29.2K
EBON icon
11210
CALL
Ebang International Holdings
EBON
$14.4M
$119K ﹤0.01%
9,883
+3,143
+47% +$76.8K
IPSC icon
11211
Century Therapeutics
IPSC
$366M
$119K ﹤0.01%
+14,152
New +$139K
TYRA icon
11212
Tyra Biosciences
TYRA
$1.49B
$119K ﹤0.01%
+16,663
New +$133K
SNPO
11213
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$119K ﹤0.01%
+12,944
New +$157K
EIGR
11214
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$119K ﹤0.01%
+629
New +$127K
SCU
11215
CALL
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$119K ﹤0.01%
+14,300
New +$158K
KBAL
11216
DELISTED
Kimball International
KBAL
$119K ﹤0.01%
15,528
-12,656
-45% -$104K
PLXP
11217
CALL
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$119K ﹤0.01%
48,900
-62,900
-56% -$175K
VLTA
11218
PUT
DELISTED
Volta Inc.
VLTA
$119K ﹤0.01%
91,400
-83,500
-48% -$186K
SREV
11219
DELISTED
ServiceSource International, Inc.
SREV
$119K ﹤0.01%
+80,962
New +$108K
ALHC icon
11220
CALL
Alignment Healthcare
ALHC
$2.83B
$118K ﹤0.01%
+10,300
New +$109K
AMBP icon
11221
PUT
Ardagh Metal Packaging
AMBP
$3.07B
$118K ﹤0.01%
19,300
-200
-1% -$1.35K
BARK icon
11222
PUT
BARK
BARK
$98.6M
$118K ﹤0.01%
4,620
-1,620
-26% -$81.7K
BLND icon
11223
CALL
Blend Labs
BLND
$360M
$118K ﹤0.01%
50,200
-12,000
-19% -$44.9K
CPSH icon
11224
PUT
CPS Technologies
CPSH
$73.7M
$118K ﹤0.01%
38,700
+3,800
+11% +$14.1K
DOLE icon
11225
PUT
Dole
DOLE
$1.3B
$118K ﹤0.01%
14,000
-16,600
-54% -$182K

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.